Nov 01,2015

Internet-delivered cognitive behaviour therapy for depression in people with diabetes: study protocol for a randomised controlled trial

Depression substantially contributes to the personal burden and healthcare costs of living with diabetes mellitus (DM). Comorbid depression and DM are associated with poorer quality of life, poorer self-management and glycemic control, increased risk for DM complications and higher mortality rates, and higher health service utilization. Depression remains under-recognized and undertreated in people with DM, which may, in part, result from barriers associated with accessing face-to-face treatment. This study will examine the efficacy of an internet-based cognitive behaviour therapy programme for major depressive disorder (iCBT-MDD) in people with DM.

CLINICAL STUDY
View Analyst & Ambassador Comments
Go to original news
Jan 06,2022

DarioHealth Announces Two New Contracts within the Employer Market

The new clients include a large Northeast regional employer in the finance industry set to deploy Dario's full suite of solutions, and a Northeast regional employer in the food industry contracted to deploy Dario's digital therapeutic solution for diabetes.

View Analyst & Ambassador Comments
Go to original news
Feb 02,2022

Patients Receiving Virta’s Diabetes Reversal Treatment See Sustained Reduction in Depressive Symptoms, New Research Shows

Virta Health , the leader in type 2 diabetes reversal, announced promising results on the impact of its diabetes reversal treatment on depressive symptoms. The research, published in The Journal of Behavioral Medicine , highlights rapid and sustained improvement in depressive symptoms during treatment, with nearly one-third fewer patients meeting the clinical cutoff for depression at two years.

CLINICAL STUDY
View Analyst & Ambassador Comments
Go to original news
Mar 09,2022

Vida Health Launches the Most Comprehensive Virtual Care Solution for Small Businesses

Vida for Small Business will provide the same 1:1 personalized care that’s available to large Vida clients like PayPal, Boeing, and Prudential.

PRODUCT

#virtual care

View Analyst & Ambassador Comments
Go to original news
May 10,2022

Vida Health Announces Medical Prescribing Services for Physical and Mental Health

Vida Health announced its expansion into new medical prescribing services for treating physical and mental health conditions together, solidifying its position as a leader in comprehensive cardiometabolic virtual care.

PRODUCT

#virtual care

View Analyst & Ambassador Comments
Go to original news
Jun 01,2022

Commencement of flash glucose monitoring is associated with a decreased rate of depressive disorders among persons with diabetes (FLARE-NL7)

This study aims to assess the effects of commencement of FreeStyle Libre flash glucose monitoring (FSL-FGM) on the mental health status of persons with diabetes.

CLINICAL STUDY

#cgm

View Analyst & Ambassador Comments
Go to original news
Jun 03,2022

DarioHealth Presents Three New Studies Demonstrating Improved Health in Users with Multiple Conditions at the American Diabetes Association's 82nd Scientific Sessions

Two of the new studies add to Dario's growing body of evidence in support of an integrated approach to managing multiple chronic conditions by examining the impact of Dario's solution on users with co-occurring physical and mental conditions. The third study analyzed the impact across the ethnicities of users living with Type 2 diabetes.

CLINICAL STUDY
View Analyst & Ambassador Comments
Go to original news
Jun 06,2022

ieso Announces Results Showing Novel Form of Online Cognitive Behavioral Therapy Improves Patient Outcomes in Type 2 Diabetes

Study results presented at the 2022 American Diabetes Association (ADA) Annual Conference, report that integrated mental healthcare in diabetes patients can improve mental health outcomes, patient engagement with self-management of diabetes, diabetes distress, and quality of life.

CLINICAL STUDY

#dtx

View Analyst & Ambassador Comments
Go to original news
Jun 21,2022

DarioHealth Announces New Contract with a National Employer

DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, today announced a new contract to deliver its digital behavioral health solution for a leading provider of integrated technology solutions for financial professionals. The new account is expected to launch in the third quarter of 2022.

View Analyst & Ambassador Comments
Go to original news
Jul 05,2022

Vida Health’s Virtual Mental Health Program Achieves Meaningful Clinical Outcomes in Reducing Depression and Anxiety

The study, Improvements in Depression Outcomes Following a Digital Cognitive Behavioral Therapy Intervention in a Polychronic Population: Retrospective Study examined the effectiveness of a therapist-supported 12-week, app-based cognitive behavioral therapy (CBT) program in improving symptoms of depression and anxiety in an adult population with a heavy burden of chronic physical disease including obesity and type 2 diabetes.

CLINICAL STUDY

#mobile app

View Analyst & Ambassador Comments
Go to original news
Subscribe to MENTAL HEALTH